MedPath

Internet-delivered cognitive behavioural therapy (iCBT) with main carer access for depression and anxiety among breast cancer survivors

Not Applicable
Completed
Conditions
Depression and anxiety symptoms in female breast cancer survivors
Mental and Behavioural Disorders
Depressive episode, anxiety disorder, unspecified
Registration Number
ISRCTN96180849
Lead Sponsor
Trinity College Dublin
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33552931/ (added 17/08/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36635249/ results (added 16/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
76
Inclusion Criteria

Breast cancer survivors and their carers (people who support them such as a partner, family member, or friend) will be recruited online and screened for eligibility using Qualtrics.

Survivors:
1. Female
2. Completed breast cancer treatment
3. At least mildly confident with using the internet
4. At least mildly confident in reading and writing in English

Main carers:
1. Currently caring or have cared for a woman living with breast cancer (such as partner, spouse, friend, or relative of the patient)
2. At least mildly confident with using the internet
3. At least mildly confident in reading and writing in English

Exclusion Criteria

1. Current suicidal ideation or intent
2. Current alcohol or drug misuse
3. Enduring mental health disorders such as schizophrenia, psychosis, and bipolar disorder
4. Currently being in treatment for depression or anxiety

As it is a pilot study, no limit has been set for the time since the treatment completion or cancer stage as an exclusion criterion for survivors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression and anxiety symptoms measured using the Hospital Anxiety and Depression Scale (HADS) at pre-test, post-test, and 2-month follow-up
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath